The novel C-Series Lamitrode® leads (ANS; Plano, TX) mimic the curve of the epidural space and are designed to direct stimulation toward the spinal cord and to minimize unwanted stimulation in the posterior epidural space. Presented are data from a prospective multi-centered study of the Genesis®XP IPG (ANS; Plano, TX) for the management of chronic pain.

Materials and Methods

This study was designed as a prospective, multi-centered, 3 month post implantation study. After Informed Consent was obtained, patients were screened according to the inclusion/exclusion criteria. The primary endpoint was to observe if there was pain reduction by using the Visual Analog Scale (VAS) at the 3 month visit. Data was also collected on overall pain relief, verbal percentage of pain relief, satisfaction, quality of life, change in medication usage and adverse events.

Results

Detailed results will be presented.

Conclusions

The C-Series Lamitrode® leads offer a safe and effective treatment for chronic pain and may help decrease the chance for lead migration.